Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker Development for Muscular Dystrophies

NCT05019625 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT05019625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05019625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker Development for Muscular Dystrophies
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Recruiting
Start date
February 20, 2015
Completion date
June 30, 2028
Enrollment
465 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

becker muscular dystrophy, duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy, myotonic dystrophy